FIGRX
Price
$51.15
Change
-$0.48 (-0.93%)
Updated
Feb 21 closing price
Net Assets
10.09B
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

FIGRX vs RERBX

Header iconFIGRX vs RERBX Comparison
Open Charts FIGRX vs RERBXBanner chart's image
Fidelity International Discovery
Price$51.15
Change-$0.48 (-0.93%)
VolumeN/A
Net Assets10.09B
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
FIGRX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIGRX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIGRX is a StrongBuy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. FIGRX (10.1B). FIGRX pays higher dividends than RERBX: FIGRX (1.72) vs RERBX (1.00). FIGRX was incepted earlier than RERBX: FIGRX (38 years) vs RERBX (23 years). FIGRX is a more actively managed with annual turnover of: 49.00 vs. RERBX (34.00). FIGRX has a lower initial minimum investment than RERBX: FIGRX (0) vs RERBX (250). FIGRX annual gain was more profitable for investors over the last year : 11.33 vs. RERBX (0.62). FIGRX return over 5 years is better than : 21.71 vs. RERBX (4.32).
FIGRXRERBXFIGRX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence38 years23 years-
Gain YTD6.7636.549103%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets10.1B131B8%
Annual Yield % from dividends1.721.00172%
Returns for 1 year11.330.621,833%
Returns for 3 years13.99-0.32-4,423%
Returns for 5 years21.714.32503%
Returns for 10 years36.8715.57237%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences